Monday Jul 21
Merck and Schering delay 2Q reports to afternoon
Schering-Plough Corp provided this undated file photo of the cholesterol-lowering drug Vytorin a product of a joint venture between pharmaceutical companies Merck & Co., and Schering-Plough Corp.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
Topic | Updated | Last By | Comments |
---|---|---|---|
Lawndale City Council blows off hookah cafe bid | 18 min | Donna Drag | 11 |
Local health care providers seek relief from pa... | 30 min | Pat | 25 |
Poll: Should the US have universal healthcare? (from Oct '07) | 33 min | Phil Gray | 28304 |
Common questions about the Engle Trust Fund | 33 min | Jumpin Jack ... | 1355 |
Marathoner can't outpace drug test | 38 min | yes sur | 18 |
County short on psychiatrists, long on waiting ... | 40 min | three genera... | 5 |
Undocumented immigrant in coma set to be return... | 40 min | Calli6 | 648 |